Meta Pixel

News and Announcements

Steve Torso: Founder of Wholesale Investor & CapitalHQ

  • Published March 23, 2026 3:51AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates, Landing, Trending

Steve Torso is the Founder and CEO of Wholesale Investor, Australia’s leading private capital marketplace, and CapitalHQ, the AI-powered Capital Engagement Agent platform transforming how companies raise capital and manage investor relationships.

Building Australia’s Private Capital Infrastructure

Steve co-founded Wholesale Investor in 2008 with a clear thesis: the gap between companies seeking private capital and investors looking to deploy into high-growth opportunities was not a discovery problem but an engagement problem. The traditional model of relying on investment banks, brokers, and word-of-mouth introductions was inefficient, expensive, and inaccessible to the majority of companies raising capital.

Over more than 14 years, Steve has built Wholesale Investor into the largest platform of its kind in Australasia, with a registered network of over 45,000 qualified investors, fund managers, family offices, and institutional participants. The platform has facilitated introductions across venture capital, private equity, pre-IPO, private credit, deep tech, health tech, fintech, and alternative assets.


The Vision for CapitalHQ

In 2024, Steve launched CapitalHQ, an AI-powered Capital Engagement Agent designed to replace the fragmented, manual, and emotionally draining process of managing investor relationships during a capital raise. CapitalHQ provides founders with an always-on system that drafts communications in their voice, tracks investor engagement through warmth signals, automates follow-ups, and provides the confidence and clarity that founders typically lack during the fundraising process.

For the advisory community, CapitalHQ operates as an operating system that scales their practice without scaling their team. The Certified Partner Programme allows advisors to earn recurring revenue from every client they serve while delivering institutional-quality investor relations powered by AI.


Thought Leadership and Industry Contribution

Steve is a recognised authority on private capital markets, capital raising strategy, and investor engagement. He is a regular contributor to the Australian Financial Review, Ausbiz, the Sydney Morning Herald, SmartCompany, and Switzer, and has delivered keynote presentations for the Australian Securities Exchange, Macquarie University, UTS, the Queensland Government, AusBiotech, Thomson Reuters, DLA Piper, and PricewaterhouseCoopers.

His annual Investor Survey, now in its latest edition with respondents across the wholesale investor community, provides one of the most detailed public datasets on private investor sentiment, sector preferences, deal structure preferences, and frustrations in the Australian market.

Connect with Steve

Steve is available for speaking engagements, partnership discussions, and media commentary on private capital markets, AI in financial services, and the future of capital raising.

LinkedIn: Steve Torso

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now